Ocrevus (ocrelizumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells. This may help to protect healthy cells from damage. Specifically it is a CD20-cytolytic antibody for the treatment of Multiple Sclerosis (MS).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
Biologics (CD20 cytolytic antibodies)
WHAT IT TREATS:
Multiple Sclerosis (MS)
Once every six months
Length of infusion:
Five hours or more
FOR MORE INFORMATION: